- Company Overview for G2B PHARMA LIMITED (10877587)
- Filing history for G2B PHARMA LIMITED (10877587)
- People for G2B PHARMA LIMITED (10877587)
- More for G2B PHARMA LIMITED (10877587)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
31 Mar 2020 | GAZ2(A) | Final Gazette dissolved via voluntary strike-off | |
14 Jan 2020 | GAZ1(A) | First Gazette notice for voluntary strike-off | |
02 Jan 2020 | DS01 | Application to strike the company off the register | |
10 Dec 2019 | TM01 | Termination of appointment of Horacio Luis De Brito Carvalho as a director on 29 November 2019 | |
11 Sep 2019 | CS01 | Confirmation statement made on 20 July 2019 with no updates | |
07 May 2019 | AA | Total exemption full accounts made up to 31 July 2018 | |
20 Dec 2018 | AD01 | Registered office address changed from Unit 12 10 Acklam Road London W10 5QZ United Kingdom to Suite a, Second Floor, Barry House 20-22 Worple Road London SW19 4DH on 20 December 2018 | |
02 Oct 2018 | TM01 | Termination of appointment of Michael Egerton Doodson as a director on 25 September 2018 | |
05 Sep 2018 | CS01 | Confirmation statement made on 20 July 2018 with no updates | |
08 Aug 2017 | AP01 | Appointment of Mr Nigel Fleming as a director on 28 July 2017 | |
03 Aug 2017 | AP01 | Appointment of Mr Horacio Luis De Brito Carvalho as a director on 21 July 2017 | |
03 Aug 2017 | AP01 | Appointment of Mr Michael Egerton Doodson as a director on 21 July 2017 | |
21 Jul 2017 | TM01 | Termination of appointment of Richard Turner as a director on 21 July 2017 | |
21 Jul 2017 | NEWINC |
Incorporation
Statement of capital on 2017-07-21
|